Abbott India Ltd.
Snapshot View

17942.70 -145.30 ▼-0.8%

27 June 2022, 04:01:00 PM
Volume: 546

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.abbott.co.in
Market Cap 38,230.04 Cr.
Enterprise Value(EV) 35,377.77 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 375.87 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 47.87 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 1,327.00 Trailing Twelve Months Ending 2022-03
Price to Book Value 13.56 Calculated using Price: 17,991.20
Dividend Yield 1.53 Period Ending 2021-03
No. of Shares Subscribed 2.12 Cr. 21,249,302 Shares
FaceValue 10
Company Profile
The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-0.80%
1 Week
+0.57%
1 Month
-0.04%
3 Month
+11.86%
6 Month
-4.41%
1 Year
+8.82%
2 Year
+12.44%
5 Year
+323.28%
10 Year
+1144.38%
9 years 2012-12 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 24.30 27.66 26.54 23.93 21.54 26.35 24.66 27.09 27.89
Return on Capital Employed (%) 36.11 41.07 39.98 37.55 33.96 40.61 37.88 36.54 37.52
Return on Assets (%) 11.41 12.96 11.20 13.39 15.12 18.01 16.90 18.36 18.78

Balance Sheet View Details

Particulars 10 years 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 647 788 938 1,196 1,387 1,693 2,009 2,432 2,602 2,820
Non Curr. Liab. 31 443 432 29 35 41 62 210 190 184
Curr. Liab. 502 652 834 382 632 668 857 891 1,031 1,203
Minority Int.
Equity & Liab. 1,179 1,883 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207
Non Curr. Assets 133 540 541 156 160 136 167 328 304 354
Curr. Assets 1,046 1,343 1,663 1,451 1,893 2,265 2,761 3,205 3,519 3,853
Misc. Exp. not W/O
Total Assets 1,179 1,883 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207

Profit Loss View Details

Particulars 10 years 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 1,653 2,276 2,289 2,615 2,903 3,299 3,679 4,093 4,310 4,919
Other Income 23 49 48 51 60 118 114 115 83 77
Total Income 1,675 2,325 2,338 2,666 2,963 3,417 3,793 4,208 4,393 4,996
Total Expenditure -1,451 -2,009 -1,978 -2,251 -2,508 -2,775 -3,075 -3,337 -3,391 -3,832
PBIDT 224 317 360 415 455 641 718 871 1,002 1,165
Interest 0 0 -1 -3 -2 -4 -2 -9 -18 -19
Depreciation -19 -22 -15 -14 -16 -16 -17 -60 -58 -66
Taxation -70 -96 -115 -143 -160 -220 -249 -210 -235 -281
Exceptional Items 10
PAT 145 198 229 255 277 401 450 593 691 799
Adjusted EPS 68 93 108 120 130 189 212 279 325 376

Cash Flow View Details

Particulars 10 years 2011-12 Rs. Cr. 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 24 101 155 215 249 307 153 499 626 727
Cash Fr. Inv. 5 -59 -144 -187 -77 -155 -215 -257 -401 -72
Cash Fr. Finan. -42 -42 -42 -58 -80 -90 -102 -143 -217 -582
Net Change -13 1 -31 -30 91 62 -165 99 8 73
Cash & Cash Eqvt 109 109 79 49 140 202 38 137 145 218

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
Public 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 31 May 2022
Submission Of Disclosure On Related Party Transactions
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22 2021 for the half year ended March 31 2022.The above disclosure is also available on the website of the Company at www.abbott.co.in. This is for your information and records.
Mon, 30 May 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Registrar and Transfer Agent of the Company KFin Technologies Limited has received request from the Shareholder for issue of Duplicate Share Certificate. Kindly acknowledge the receipt of the same.
Wed, 25 May 2022
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24(A) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby enclose Secretarial Compliance Report for the year ended March 31 2022 in the prescribed format issued by Ms Neena Bhatia Practicing Company Secretary.

Technical Scans View Details

Mon, 27 Jun 2022
High Increase 3 Months High Increase 3 Months
High Increase 5 Years High Increase 5 Years
Closing Near 20 SMA Closing Near 20 SMA
ROC Trending Down ROC Trending Down
Fri, 24 Jun 2022
Opening at Low Opening at Low

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Abbott India Ltd.

Can I Buy Abbott India Shares now?

What is the Share Price of Abbott India?

What is the Relative Strength Index (RSI) Value of Abbott India?

What is the Market Capital (MCAP) of Abbott India?

What are the key metrics to analyse Abbott India?

What is the Price Performance of Abbott India?